. . . . . . . "[The development of Her-2 DNA vaccine has progressed through three phases that can be categorized as phase 'A': the pursuit of Her-2 as a tumor-associated 'antigen', phase 'B': tilting the 'balance' between tumor immunity and autoimmunity and phase 'C': the on-going 'clinical trials'.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:20+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .